Cas 254435-06-8,N,N′-bis(2-aminophenyl)-1,4-benzenedimethanamine

254435-06-8

Post Buying Request

Basic information

Product Name: N,N′-bis(2-aminophenyl)-1,4-benzenedimethanamine
Synonyms: N,N′-bis(2-aminophenyl)-1,4-benzenedimethanamine
CAS NO:254435-06-8
Molecular Formula:
Molecular Weight: 318.421
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: N,N′-bis(2-aminophenyl)-1,4-benzenedimethanamine(CAS DataBase Reference)
NIST Chemistry Reference: N,N′-bis(2-aminophenyl)-1,4-benzenedimethanamine(254435-06-8)
EPA Substance Registry System: N,N′-bis(2-aminophenyl)-1,4-benzenedimethanamine(254435-06-8)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 254435-06-8(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

254435-06-8 Suppliers

Recommended suppliers

254435-06-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 254435-06-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,5,4,4,3 and 5 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 254435-06:
(8*2)+(7*5)+(6*4)+(5*4)+(4*3)+(3*5)+(2*0)+(1*6)=128
128 % 10 = 8
So 254435-06-8 is a valid CAS Registry Number.

254435-06-8Upstream product

254435-06-8Downstream Products

254435-06-8Relevant academic research and scientific papers

Synthetic and structural investigations of bis(N -alkyl-benzoselenadiazolium) cations

Lee, Lucia Myongwon,Corless, Victoria,Luu, Helen,He, Allan,Jenkins, Hilary,Britten, James F.,Adam Pani, Faisal,Vargas-Baca, Ignacio

, p. 12541 - 12548 (2019)

The synthesis, and spectroscopic and structural characterization of bridged dicationic derivatives of benzo-2,1,3-selenadiazoles are reported. The chloride salt of [H4C6NSeN-CH2-CH2-NSeNC6H4/sub

Bis (benzimidazole) derivatives serving as potassium blocking agents

-

, (2008/06/13)

This invention relates to novel potassium channel blocking agents, and their use in the preparation of pharmaceutical compositions. Moreover the invention is directed to pharmaceutical compositions useful for the treatment or alleviation of diseases or disorders associated with the activity of potassium channels, in particular asthma, cystic fibrosis, chronic obstructive pulmonary disease and rhinorrhea, convulsions, vascular spasms, coronary artery spasms, renal disorders, polycystic kidney disease, bladder spasms, urinary incontinence, bladder outflow obstruction, irritable bowel syndrome, gastrointestinal dysfunction, secretory diarrhoea, ischaemia, cerebral ischaemia, ischaemic hearth disease, angina pectoris, coronary hearth disease, traumatic brain injury, psychosis, anxiety, depression, dementia, memory and attention deficits, Alzheimer's disease, dysmenorrhea, narcolepsy, Reynaud's disease, intermittent claudication, Sjorgren's syndrome, migraine, arrhythmia, hypertension, absence seizures, myotonic muscle dystrophia, xerostomi, diabetes type II, hyperinsulinemia, premature labor, baldness, cancer, and immune suppression.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 254435-06-8